Patents/Assignees

OCGENE THERAPEUTICS CORPORATION

1 patent in portfolio

US11970713utility2024
Method for Long-term Ex Vivo Maintenance or Expansion of Human Erythroblast, Human Megakaryocyte-erythroid Progenitor, or Human Common Myeloid Progenitor Cell and Application Thereof
0 cites